Cancer Cachexia - Pipeline Review, H2 2015

1
Cancer Cachexia - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Cancer Cachexia
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Cancer Cachexia and
  enlists all their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Cancer Cachexia products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Cancer Cachexia pipeline on the
  basis of target, MoA, route of administration and
  molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/cancer-
  cachexia-pipeline-review-h2-2015-market

3


Table of Content
Table of Contents 2List of Tables 6List of
Figures 7Introduction 8Global Markets Direct
Report Coverage 8Cancer Cachexia Overview
9Therapeutics Development 10Pipeline Products
for Cancer Cachexia - Overview 10Pipeline
Products for Cancer Cachexia - Comparative
Analysis 11Cancer Cachexia - Therapeutics under
Development by Companies 12Cancer Cachexia -
Therapeutics under Investigation by
Universities/Institutes 14Cancer Cachexia -
Pipeline Products Glance 15Late Stage Products
15Clinical Stage Products 16Early Stage
Products 17Cancer Cachexia - Products under
Development by Companies 18Cancer Cachexia -
Products under Investigation by
Universities/Institutes 20Cancer Cachexia -
Companies Involved in Therapeutics Development
21Acacia Pharma Limited 21Aeterna Zentaris Inc.
22
4


Report Overview
List of Figures Number of Products under
Development for Cancer Cachexia, H2 2015
10Number of Products under Development for
Cancer Cachexia - Comparative Analysis, H2 2015
11Number of Products under Development by
Companies, H2 2015 12Comparative Analysis by
Clinical Stage Development, H2 2015
16Comparative Analysis by Early Stage Products,
H2 2015 17Assessment by Monotherapy Products, H2
2015 39Number of Products by Top 10 Targets, H2
2015 41Number of Products by Stage and Top 10
Targets, H2 2015 41Number of Products by Top 10
Mechanism of Actions, H2 2015 43Number of
Products by Stage and Top 10 Mechanism of
Actions, H2 2015 43Number of Products by Top 10
Routes of Administration, H2 2015 45Number of
Products by Stage and Top 10 Routes of
Administration, H2 2015 45Number of Products by
Top 10 Molecule Types, H2 2015 47Number of
Products by Stage and Top 10 Molecule Types, H2
2015 47 Enquire At http//www.researchbeam.com
/cancer-cachexia-pipeline-review-h2-2015-market/en
quire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/cancer-cachexia-pipeli
ne-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com